Bei Akademie registrieren
Grifols, ES0171996087

Grifols stock pre-market at EUR 10.05 ahead of the Xetra open

Published on 10/23/2026 at 08:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The company develops and distributes plasma-derived therapies and other healthcare products. At Lang & Schwarz the stock trades pre-market at EUR 10.05 on October 23, 2026.

Plasma business and market context

  • Grifols develops and distributes therapeutic products, primarily those derived from human plasma.
  • Spain's benchmark is the IBEX 35.
  • Grifols stock trades pre-market at EUR 10.05 at 8:39 a.m. CEST at Lang & Schwarz on October 23, 2026.
3D-Architekturrender eines modernen Biotech-Forschungscampus mit Glasfassade
Architektur-Render eines modernen Forschungscampus visualisiert die Infrastruktur von Grifols S.A. ES0171996087 im Biotech-Sektor, Illustration mit AI erstellt.

Grifols develops, manufactures and distributes therapeutic products, primarily those derived from human plasma, according to its investor information. At Lang & Schwarz, Grifols stock trades pre-market at EUR 10.05 at 8:39 a.m. CEST on October 23, 2026.

Ahead of the Xetra open

The Lang & Schwarz indication places the stock ahead of the Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Grifols stock.

Plasma therapies and the market

Grifols earns revenue from healthcare products and services spanning plasma-derived medicines, hospital products, diagnostics and biological supplies. Market context: Market report IBEX 35.

More news and analysis on Grifols stock

Disclaimer...
en | ES0171996087 | GRIFOLS | boerse | 70396962 | bgmi